Versions Compared

Old Version 10

changes.mady.by.user Wendy Dobson

Saved on

compared with

New Version Current

changes.mady.by.user Alex Pearce

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Image Modified


Project

Scope

Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.



Project LeadsEmail

Melvin Munsaka

  

, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Wendy Dobson (

Nicola Newton, PHUSE Project

Manager)

Assistant

wendy@phuse

nicky@phuse.

eu

global

Deliverables


Status

Timelines

colour

Project Members

Blue

Company

title

Amelia PangSanofiEileen Navarro AlmarioFDAJohn MarcianoAbbviePatrick HannonMMS HoldingsPreeti VenkataramanFDASwarnalatha ReddyCovanceVeronical Pei YangFDAWilliam Palo 

Current Status
Q1 2024

  • FDA comments incorporated into the WP



Objectives & Deliverables

Timelines 

Finalise Stage 1 of draft White Paper

Q4 2023
Abbvie